IGF1 and type 2 diabetes mellitus: Alongside improved insulin sensitivity in both groups, serum IGF-I increased in the T2D group only, while fasting serum cortisol decreased in T2D subjects and unexpectedly increased in IGT subjects, who displayed higher reactivity to low-dose ACTH compared to T2D subjects during treatment.